Synonyms: AEZS-130 | AEZS130 | Aib-DTrp-DgTrp-CHO | EP-1572 | EP1572 | UMV1843
macimorelin is an approved drug (FDA (2017), EMA (2019))
Compound class:
Synthetic organic
Comment: Macimorelin is a ghrelin peptidomimetic [2]. It is a growth hormone (GH) secretagogue. The approved drug is the acetate salt (PubChem CID 71526737)- we show the parent molecule in this entry.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Agrawal V, Garcia JM. (2014)
The macimorelin-stimulated growth hormone test for adult growth hormone deficiency diagnosis. Expert Rev Mol Diagn, 14 (6): 647-54. [PMID:24834478] |
2. Broglio F, Boutignon F, Benso A, Gottero C, Prodam F, Arvat E, Ghè C, Catapano F, Torsello A, Locatelli V et al.. (2002)
EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. J Endocrinol Invest, 25 (8): RC26-8. [PMID:12240910] |
3. Garcia JM, Swerdloff R, Wang C, Kyle M, Kipnes M, Biller BM, Cook D, Yuen KC, Bonert V, Dobs A et al.. (2013)
Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab, 98 (6): 2422-9. [PMID:23559086] |